onmedic news: ReliantHeart goes head-to-head with Thoratec to aim for U.S. LVAD market

dilluns, 7 d’abril del 2014

ReliantHeart goes head-to-head with Thoratec to aim for U.S. LVAD market

ReliantHeart touts study data finding that its HeartAssist5 left ventricular assist device poses a lower risk of blood clots and damage compared with Thoratec's HeartMate II.

ReliantHeart aims for U.S. LVAD market, goes head-to-head with Thoratec

ReliantHeart, Thoratec Corp.

News Well, Clinical Trials, Cardiac Assist Devices, Cardiac Implants, Implants

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qfdand

onmedic news

dilluns, 7 d’abril del 2014

ReliantHeart goes head-to-head with Thoratec to aim for U.S. LVAD market

Cap comentari:

Publica un comentari a l'entrada